Our results imply that cervical cancer tissues with reduced GLTSCR2 expression have a chance for enhanced growth potential through up-regulated NPM expression and that GLTSCR2 might participate in suppression of tumourigenesis via NPM repression in cervical cancer. Here, NOP53 is linked to cervical cancer.